Skip to main content
Have a personal or library account? Click to login
Regulatory Role of Peritoneal B Cells in EAE Cover

Regulatory Role of Peritoneal B Cells in EAE

EABR. Experimental and Applied Biomedical Research
Volume 17 (2016): Issue 2 (June 2016)
By: ,  ,  ,   and    
Open Access
|Jun 2016
References

References

  1. 1. Crampton SP, Voynova E, Bolland S. Innate pathways to B-cell activation and tolerance. Ann N Y Acad Sci. 2010; 1183: 58-68.
    Open DOISearch in Google Scholar
  2. 2. Meyer-Bahlburg A, Rawlings DJ. B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev. 2008; 7(4): 313-316.
    Open DOISearch in Google Scholar
  3. 3. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol. 1993; 11: 501-538.
    Open DOISearch in Google Scholar
  4. 4. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011; 11(1): 34-46.
    Open DOISearch in Google Scholar
  5. 5. Montecino-Rodriguez E, Dorshkind K. B-1 B cell development in the fetus and adult. Immunity. 2012; 36(1): 13-21.
    Open DOISearch in Google Scholar
  6. 6. O’Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol. 1990; 2(9): 821-832.
    Open DOISearch in Google Scholar
  7. 7. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005 ;23: 683-747.
    Open DOISearch in Google Scholar
  8. 8. Ben-Nun A, Cohen IR. Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line. Eur J Immunol. 1981; 11(11): 949-952.
    Open DOISearch in Google Scholar
  9. 9. Costantino CM, Baecher-Allan C, Hafler DA. Multiple sclerosis and regulatory T cells. J Clin Immunol. 2008; 28(6): 697-706.
    Open DOISearch in Google Scholar
  10. 10. O’Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol. 2008; 193(1-2): 1-11.
    Open DOISearch in Google Scholar
  11. 11. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16(2): 249-256.
    Open DOISearch in Google Scholar
  12. 12. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood.2008; 112(5): 1570-1580.
    Open DOISearch in Google Scholar
  13. 13. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev. 2008; 223: 284-299.
    Open DOISearch in Google Scholar
  14. 14. Bouaziz JD, Yanaba K, Venturi GM, et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A. 2007; 104(52): 20878-20883.
    Open DOISearch in Google Scholar
  15. 15. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin Immunol. 2008; 20(3): 332-338.
    Open DOISearch in Google Scholar
  16. 16. Hauser SL, Waubant E, Arnold DL, et al., HERMES Trial Group. B-cell depletion with rituximab in relapsing- remitting multiple sclerosis. N Engl J Med. 2008; 358(7): 676-688.
    Open DOISearch in Google Scholar
  17. 17. Bar-Or A, Calabresi PA, Arnold D, et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, openlabel, phase I trial. Ann Neurol. 2008; 63(3): 395-400.
    Open DOISearch in Google Scholar
  18. 18. Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007; 178(10): 6092-6099.
    Open DOISearch in Google Scholar
  19. 19. Torring C, Petersen CC, Bjerg L, Kofod-Olsen E, Petersen T, Hollsberg P. The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol. 2013; 262(1-2): 92-99.
    Open DOISearch in Google Scholar
  20. 20. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008; 118(10): 3420-3430.
    Open DOISearch in Google Scholar
  21. 21. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996; 184(6): 2271-2278.
    Open DOISearch in Google Scholar
  22. 22. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3(10): 944-950.
    Open DOISearch in Google Scholar
  23. 23. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16(2): 219-230.
    Open DOISearch in Google Scholar
  24. 24. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197(4): 489-501.
    Open DOISearch in Google Scholar
  25. 25. Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008; 8(5): 391-397.
    Open DOISearch in Google Scholar
  26. 26. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30: 221-241.
    Open DOISearch in Google Scholar
  27. 27. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007; 178(12): 7868-7878.
    Open DOISearch in Google Scholar
  28. 28. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010; 1183: 38-57.
    Open DOISearch in Google Scholar
  29. 29. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28(5): 639-650.
    Open DOISearch in Google Scholar
  30. 30. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012; 491(7423): 264-268.
    Open DOISearch in Google Scholar
  31. 31. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol. 2009; 182(12): 7459-7472.
    Open DOISearch in Google Scholar
  32. 32. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 1998; 161(7): 3299-3306.
    Open DOISearch in Google Scholar
  33. 33. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol. 2008; 180(7): 4763-4773.
    Open DOISearch in Google Scholar
  34. 34. Horikawa M, Minard-Colin V, Matsushita T, Tedder TF. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest. 2011; 121(11): 4268-4280.
    Open DOISearch in Google Scholar
  35. 35. Miles K, Heaney J, Sibinska Z, et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A. 2012; 109(3): 887-892.
    Open DOISearch in Google Scholar
  36. 36. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197(4): 489-501.
    Open DOISearch in Google Scholar
  37. 37. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009; 182(6): 3492-3502.
    Open DOISearch in Google Scholar
  38. 38. Poe JC, Smith SH, Haas KM, et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One. 2011; 6(7): e22464.
    Open DOISearch in Google Scholar
  39. 39. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012; 491(7423): 264-268.
    Open DOISearch in Google Scholar
  40. 40. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000; 192(4): 475-482.
    Open DOISearch in Google Scholar
  41. 41. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010; 185(4): 2240-2252.
    Open DOISearch in Google Scholar
  42. 42. Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011; 186(10): 5569-5579.
    Open DOISearch in Google Scholar
  43. 43. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010; 125(5): 1114-1124.
    Open DOISearch in Google Scholar
  44. 44. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A. 2007; 104(35): 14080-14085.
    Open DOISearch in Google Scholar
  45. 45. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001; 167(2): 1081-1089.
    Open DOISearch in Google Scholar
  46. 46. Byrne SN, Halliday GM. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol. 2005; 124(3): 570-578.
    Open DOISearch in Google Scholar
  47. 47. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 1998; 187(4): 537-546.
    Open DOISearch in Google Scholar
  48. 48. Peterson LK, Tsunoda I, Fujinami RS. Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity. 2008; 41(5): 353-362.
    Open DOISearch in Google Scholar
  49. 49. Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc Natl Acad Sci U S A. 2002; 99(5): 3013-3017.
    Open DOISearch in Google Scholar
  50. 50. Maseda D, Candando KM, Smith SH, et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN- γ+CD4+ T cell numbers during colitis development in mice. J Immunol. 2013; 191(5): 2780-2795.
    Open DOISearch in Google Scholar
  51. 51. Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc Natl Acad Sci U S A. 2002; 99(5): 3013-3017.
    Open DOISearch in Google Scholar
  52. 52. Jiang HR, Milovanović M, Allan D, et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol. 2012; 42(7): 1804-1814.
    Open DOISearch in Google Scholar
  53. 53. Milovanovic M, Volarevic V, Ljujic B, et al. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS One.2012; 7(9): e45225.
    Open DOISearch in Google Scholar
  54. 54. Itakura A, Szczepanik M, Campos RA, et al. An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol. 2005; 175(11): 7170-7178.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0048 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 87 - 92
Submitted on: Sep 2, 2015
Accepted on: Sep 8, 2015
Published on: Jun 10, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
multiple sclerosis,
EAE,
B cells,
peritoneal regulatory B cells
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Bojana Stojanović, Jelena Milovanović, Aleksandar Arsenijević, Marija Milovanovic, Miodrag L. Lukic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 17 (2016): Issue 2 (June 2016)
Next article